Wall Street Zen Upgrades Zepp Health (NYSE:ZEPP) to Hold

Zepp Health (NYSE:ZEPP) was upgraded by investment analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Saturday.

Separately, Fundamental Research set a $56.28 target price on shares of Zepp Health and gave the company a “buy” rating in a report on Wednesday, April 22nd. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $56.28.

Zepp Health Stock Performance

NYSE:ZEPP opened at $5.42 on Friday. The firm’s fifty day moving average price is $6.54 and its 200 day moving average price is $14.69. Zepp Health has a 1-year low of $3.85 and a 1-year high of $61.85. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.88 and a quick ratio of 0.67. The firm has a market cap of $79.57 million, a price-to-earnings ratio of -2.15 and a beta of 1.83.

Insider Buying and Selling at Zepp Health

In related news, CFO Cheng Deng sold 9,836 shares of the company’s stock in a transaction that occurred on Friday, June 26th. The stock was sold at an average price of $4.61, for a total value of $45,343.96. Following the sale, the chief financial officer owned 114,539 shares in the company, valued at $528,024.79. This represents a 7.91% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Zepp Health

Hedge funds and other institutional investors have recently bought and sold shares of the company. Public Employees Retirement System of Ohio acquired a new stake in Zepp Health in the third quarter valued at $43,000. Osaic Holdings Inc. increased its position in shares of Zepp Health by 239.5% in the fourth quarter. Osaic Holdings Inc. now owns 8,285 shares of the company’s stock valued at $223,000 after buying an additional 5,845 shares in the last quarter. Dimensional Fund Advisors LP acquired a new position in shares of Zepp Health during the 4th quarter worth $241,000. Capstone Capital Management Ltd acquired a new position in shares of Zepp Health during the 4th quarter worth $298,000. Finally, Mangrove Partners IM LLC purchased a new stake in shares of Zepp Health in the 4th quarter worth about $387,000. 52.61% of the stock is owned by institutional investors and hedge funds.

Zepp Health Company Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.